Market Outlook
The global Swine Reproductive and Respiratory Syndrome Vaccine market size was valued at USD 436.7 million in 2022 and is forecast to a readjusted size of USD 838.1 million by 2029 with a CAGR of 9.8% during review period.
Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Boehringer ingelheim is the company with the largest market share, about 25 percent.
This report is a detailed and comprehensive analysis for global Swine Reproductive and Respiratory Syndrome Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Swine Reproductive and Respiratory Syndrome Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Swine Reproductive and Respiratory Syndrome Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Swine Reproductive and Respiratory Syndrome Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Swine Reproductive and Respiratory Syndrome Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Reproductive and Respiratory Syndrome Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Swine Reproductive and Respiratory Syndrome Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Segmentation By Type
Active Vaccine
Inactivated Vaccines
Segmentation By Application
Government Tender
Market Sales
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Swine Reproductive and Respiratory Syndrome (SRRS) Vaccine Market in 2025?
The SRRS vaccine market benefits from a growing awareness of animal health, increasing demand for pork globally, and advancements in vaccine development. Innovations in vaccine formulations are improving efficacy, leading to a greater adoption rate in both developed and emerging markets. Furthermore, the regulatory approval process has become more streamlined, allowing vaccines to reach the market faster.
What are the weaknesses of the SRRS Vaccine Market in 2025?
Despite the growth, the market faces challenges such as high production costs and limited access to vaccines in developing regions. Additionally, the variability in vaccine effectiveness across different swine populations and strains of the virus can pose concerns for farmers. The lack of uniform global standards and regulations can also hinder growth in certain regions.
What opportunities exist for the SRRS Vaccine Market in 2025?
There are significant opportunities in expanding the market in developing regions with rising pork consumption. Advancements in biotechnology may lead to more cost-effective and highly effective vaccines, addressing current gaps. Partnerships between vaccine manufacturers, governmental bodies, and agricultural organizations can drive greater awareness and access to vaccines, leading to broader adoption.
What threats could impact the SRRS Vaccine Market in 2025?
The SRRS vaccine market may face threats from potential regulatory hurdles, particularly in regions with stringent approval processes. Emerging new strains of the virus that are not covered by current vaccines could limit the effectiveness of existing solutions. Additionally, the growth of alternative protein sources may reduce the overall demand for pork, indirectly affecting the market for SRRS vaccines.
Market PESTEL Analysis
What political factors could influence the Swine Reproductive and Respiratory Syndrome (SRRS) Vaccine Market in 2025?
Political stability and government policies on animal health and agriculture significantly impact vaccine development and distribution. Government support in the form of subsidies or incentives for vaccine producers and farmers can drive market growth. Trade regulations, especially in international markets, could also affect vaccine distribution across borders.
How could economic factors affect the SRRS Vaccine Market in 2025?
Economic factors such as the global demand for pork, pricing pressure, and income levels in various regions directly influence the market. In regions with economic growth and higher disposable incomes, the demand for vaccines increases. However, during economic downturns, producers may cut costs, leading to reduced vaccine adoption.
What social factors will play a role in the SRRS Vaccine Market in 2025?
Increasing awareness about animal health and the rising demand for safer and healthier food products will drive the SRRS vaccine market. Public concern over foodborne illnesses and the sustainability of the meat industry will encourage pork producers to invest in disease prevention measures like vaccination.
How could technological advancements impact the SRRS Vaccine Market in 2025?
Technological advancements in vaccine development, including improved formulations, delivery methods, and diagnostic tools, will enhance the effectiveness of SRRS vaccines. The use of biotechnology and precision medicine in animal health is expected to drive innovations, leading to more affordable and efficient vaccine solutions.
What environmental factors could affect the SRRS Vaccine Market in 2025?
Environmental factors such as climate change and the spread of diseases due to shifting ecosystems can influence the SRRS vaccine market. Climate-related stresses on livestock populations might increase vulnerability to diseases, thus intensifying the need for effective vaccines to protect animal health and ensure stable pork production.
What legal factors need to be considered for the SRRS Vaccine Market in 2025?
Strict regulations regarding vaccine approval, safety, and efficacy are critical to ensuring the successful introduction and use of SRRS vaccines. Compliance with international standards and local regulations is essential for vaccine manufacturers to expand their market reach. Intellectual property laws may also influence research and development efforts.
Market SIPOC Analysis
Who are the suppliers in the SRRS Vaccine Market in 2025?
The suppliers include pharmaceutical companies, biotechnology firms, and research institutions that specialize in vaccine development. They provide the raw materials, research, and technological innovations required for creating effective vaccines. Suppliers of adjuvants, antigens, and other biological components also play a significant role.
Who are the inputs in the SRRS Vaccine Market in 2025?
Inputs in the SRRS vaccine market include research data, clinical trial results, raw materials for vaccine production, and regulatory guidelines. These inputs are crucial for developing safe and effective vaccines. Investment in R&D and access to advanced biotechnology are key factors that drive the market forward.
What processes are involved in the SRRS Vaccine Market in 2025?
The key processes include research and development, clinical trials, regulatory approval, manufacturing, and distribution. Vaccine developers work on formulating and testing vaccines, while regulatory bodies ensure they meet safety and efficacy standards. After approval, vaccines are mass-produced and distributed to veterinary clinics and farms.
Who are the customers in the SRRS Vaccine Market in 2025?
The primary customers include swine producers, veterinary clinics, animal health organizations, and government agencies involved in agriculture and animal welfare. Additionally, large-scale pork producers and industry stakeholders who prioritize animal health and biosecurity also constitute a significant portion of the customer base.
What are the outputs of the SRRS Vaccine Market in 2025?
The outputs are the SRRS vaccines, which are distributed and used to protect pigs from reproductive and respiratory diseases. These vaccines aim to improve herd health, reduce mortality rates, and enhance the overall productivity of the pork industry.
Market Porter's Five Forces
How strong is the threat of new entrants in the SRRS Vaccine Market in 2025?
The threat of new entrants is moderate. While there is potential for growth in the SRRS vaccine market, high barriers to entry exist, including significant investment in research and development, regulatory approvals, and the need for specialized knowledge in veterinary medicine. Established companies have strong brand recognition and distribution networks, making it harder for new players to gain market share.
How intense is the bargaining power of suppliers in the SRRS Vaccine Market in 2025?
The bargaining power of suppliers is moderate to high. Key suppliers of raw materials, such as antigens and adjuvants, have some leverage, as there are few specialized producers for these critical components. However, large vaccine manufacturers often have the scale and capabilities to mitigate this power through strategic partnerships or by developing in-house production capabilities.
How high is the bargaining power of buyers in the SRRS Vaccine Market in 2025?
The bargaining power of buyers is moderate. While swine producers and veterinary clinics have some influence on pricing due to the availability of alternative vaccines or treatments, the need for effective solutions to control SRRS creates a somewhat inelastic demand. Producers are often willing to pay for vaccines that ensure the health and productivity of their herds, especially as disease outbreaks can be costly.
What is the threat of substitute products in the SRRS Vaccine Market in 2025?
The threat of substitutes is low. While alternative methods such as biosecurity measures, improved herd management practices, and antibiotic treatments exist, they are not as effective as vaccines in preventing SRRS. Vaccines remain the most reliable long-term solution for controlling the disease, making substitutes less appealing in the face of growing industry demand for disease prevention.
How intense is the competitive rivalry in the SRRS Vaccine Market in 2025?
Competitive rivalry is moderate to high. The SRRS vaccine market has a few dominant players, but there is still significant competition as companies invest in developing more effective, cost-efficient vaccines. Innovation, pricing strategies, and regulatory approvals can create shifts in market share. Companies are constantly competing to offer the best protection for swine populations, especially as demand for vaccines grows.
Market Upstream Analysis
What are the key suppliers in the SRRS Vaccine Market in 2025?
The key suppliers include pharmaceutical companies, biotech firms, and specialized suppliers of antigens, adjuvants, and raw materials for vaccine development. Research institutions also play a significant role in providing the scientific data and breakthroughs necessary for developing new vaccine formulations.
What are the raw materials and resources required for the SRRS vaccine production?
Raw materials and resources include viral antigens specific to the SRRS virus, adjuvants to enhance immune response, and stabilizers to ensure vaccine efficacy and shelf life. Additionally, specialized facilities, skilled labor, and advanced laboratory equipment are necessary for research, testing, and large-scale production.
What role do research and development play in the upstream segment of the SRRS Vaccine Market?
Research and development (R&D) are critical to advancing vaccine technology and ensuring the development of safe, effective vaccines. R&D efforts focus on understanding the virus, identifying new strains, improving vaccine formulations, and ensuring vaccines meet regulatory standards for safety and efficacy. Companies invest heavily in R&D to maintain competitive advantage.
What challenges do upstream suppliers face in the SRRS vaccine market?
Upstream suppliers face challenges such as the high cost of production, regulatory hurdles, and the complexity of producing specialized biological materials. The need for continuous innovation to address evolving strains of the SRRS virus also adds pressure. Additionally, ensuring a reliable and consistent supply chain for raw materials is critical for vaccine manufacturers.
How does the regulatory environment affect upstream operations in the SRRS Vaccine Market?
The regulatory environment significantly impacts upstream operations by setting stringent guidelines for vaccine development, testing, and manufacturing. Suppliers must adhere to international and local regulations to ensure their products meet safety and quality standards. Delays in regulatory approvals or changes in regulatory policies can disrupt the production timelines for vaccine components.
Market Midstream Analysis
What are the key players in the midstream segment of the SRRS Vaccine Market in 2025?
Key players in the midstream segment include vaccine manufacturers, production facilities, and contract manufacturers. These players are responsible for the mass production of SRRS vaccines, ensuring quality control, scalability, and efficient distribution to various markets.
What processes are involved in the midstream segment of the SRRS Vaccine Market?
The processes in the midstream segment involve large-scale manufacturing, quality assurance, packaging, and distribution. Vaccine producers convert raw materials into finished products, adhering to strict regulatory standards. They then manage the logistics to deliver vaccines to veterinary clinics, swine producers, and other customers.
How does the supply chain work in the midstream segment of the SRRS Vaccine Market?
The supply chain in the midstream segment starts with the receipt of raw materials from upstream suppliers, followed by vaccine production, quality testing, and packaging. Once vaccines are ready, they are distributed through various channels, including wholesalers, distributors, and veterinary networks. Ensuring a smooth, efficient distribution system is essential to meeting demand and preventing delays.
What challenges do midstream players face in the SRRS vaccine market?
Midstream players face challenges such as maintaining consistent vaccine quality and meeting regulatory compliance standards. Production scalability to meet fluctuating demand and the need for cold chain logistics to maintain vaccine efficacy during transportation are also significant hurdles. Additionally, cost pressures and competition may impact profit margins.
How do midstream operations impact vaccine availability and market dynamics?
Midstream operations play a crucial role in ensuring timely and consistent vaccine availability. Efficient manufacturing and distribution directly impact how quickly vaccines reach swine producers and veterinarians, which in turn influences herd health and productivity. Delays or inefficiencies in the midstream process can disrupt the supply chain and impact the market's overall growth and stability.
Market Downstream Analysis
Who are the key players in the downstream segment of the SRRS Vaccine Market in 2025?
Key players in the downstream segment include swine producers, veterinary clinics, animal health organizations, and government agencies involved in agriculture. These stakeholders are responsible for purchasing and administering the SRRS vaccines to protect animal health and ensure stable pork production.
What are the key activities in the downstream segment of the SRRS Vaccine Market?
Key activities include vaccine administration, monitoring herd health, and ensuring compliance with vaccination protocols. Veterinary professionals and swine producers play critical roles in assessing the need for vaccination, administering the vaccines, and tracking the effectiveness of vaccination programs in preventing disease outbreaks.
What challenges do downstream players face in the SRRS vaccine market?
Downstream players face challenges such as the cost of vaccines, ensuring timely administration across large herds, and addressing vaccine effectiveness concerns due to viral strain variations. Limited access to vaccines in certain regions, logistical issues, and managing vaccine storage and handling also present significant barriers.
How does the downstream segment influence vaccine adoption in the SRRS Vaccine Market?
The downstream segment influences vaccine adoption by directly impacting the end-users, such as swine producers, who make decisions based on the perceived effectiveness, cost, and ease of vaccine administration. If vaccines prove effective in controlling SRRS outbreaks and improving herd productivity, it leads to higher adoption rates in the industry.
What is the role of customer education in the downstream segment of the SRRS Vaccine Market?
Customer education plays a critical role in ensuring that swine producers and veterinarians understand the importance of SRRS vaccination and its role in maintaining herd health. Educating customers on vaccine benefits, proper administration, and disease prevention strategies can lead to better vaccine uptake and more successful disease control efforts.
Chapter 1, to describe Swine Reproductive and Respiratory Syndrome Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, with price, sales, revenue and global market share of Swine Reproductive and Respiratory Syndrome Vaccine from 2018 to 2023.
Chapter 3, the Swine Reproductive and Respiratory Syndrome Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Reproductive and Respiratory Syndrome Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Swine Reproductive and Respiratory Syndrome Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Reproductive and Respiratory Syndrome Vaccine.
Chapter 14 and 15, to describe Swine Reproductive and Respiratory Syndrome Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Swine Reproductive and Respiratory Syndrome Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Active Vaccine
1.3.3 Inactivated Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Government Tender
1.4.3 Market Sales
1.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size & Forecast
1.5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (2018-2029)
1.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 ASCENT CORPORATION
2.1.1 ASCENT CORPORATION Details
2.1.2 ASCENT CORPORATION Major Business
2.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ASCENT CORPORATION Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 MSD Animal Health
2.3.1 MSD Animal Health Details
2.3.2 MSD Animal Health Major Business
2.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 MSD Animal Health Recent Developments/Updates
2.4 SPAH
2.4.1 SPAH Details
2.4.2 SPAH Major Business
2.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SPAH Recent Developments/Updates
2.5 Ceva
2.5.1 Ceva Details
2.5.2 Ceva Major Business
2.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ceva Recent Developments/Updates
2.6 Chengdu TECH-BANK Biological Products Co,.Ltd
2.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Details
2.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Major Business
2.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments/Updates
2.7 ringpu
2.7.1 ringpu Details
2.7.2 ringpu Major Business
2.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 ringpu Recent Developments/Updates
2.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
2.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Details
2.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Major Business
2.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments/Updates
2.9 DAHUANONG
2.9.1 DAHUANONG Details
2.9.2 DAHUANONG Major Business
2.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DAHUANONG Recent Developments/Updates
2.10 CAVAC
2.10.1 CAVAC Details
2.10.2 CAVAC Major Business
2.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CAVAC Recent Developments/Updates
2.11 Komipharm
2.11.1 Komipharm Details
2.11.2 Komipharm Major Business
2.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Komipharm Recent Developments/Updates
2.12 Agrovet
2.12.1 Agrovet Details
2.12.2 Agrovet Major Business
2.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Agrovet Recent Developments/Updates
2.13 Bioveta
2.13.1 Bioveta Details
2.13.2 Bioveta Major Business
2.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bioveta Recent Developments/Updates
2.14 JINYU BIO-TECNOLOGY CO.,LTD
2.14.1 JINYU BIO-TECNOLOGY CO.,LTD Details
2.14.2 JINYU BIO-TECNOLOGY CO.,LTD Major Business
2.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments/Updates
2.15 Phibro Animal Health
2.15.1 Phibro Animal Health Details
2.15.2 Phibro Animal Health Major Business
2.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Phibro Animal Health Recent Developments/Updates
2.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
2.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Details
2.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Major Business
2.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments/Updates
2.17 Zoetis
2.17.1 Zoetis Details
2.17.2 Zoetis Major Business
2.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Zoetis Recent Developments/Updates
2.18 WINSUN BIO
2.18.1 WINSUN BIO Details
2.18.2 WINSUN BIO Major Business
2.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 WINSUN BIO Recent Developments/Updates
2.19 PULIKE BIOLOGICAL ENGINERING,INC.
2.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Details
2.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Major Business
2.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
2.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments/Updates
3 Competitive Environment: Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturer Market Share in 2022
3.5 Swine Reproductive and Respiratory Syndrome Vaccine Market: Overall Company Footprint Analysis
3.5.1 Swine Reproductive and Respiratory Syndrome Vaccine Market: Region Footprint
3.5.2 Swine Reproductive and Respiratory Syndrome Vaccine Market: Company Product Type Footprint
3.5.3 Swine Reproductive and Respiratory Syndrome Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Region (2018-2029)
4.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029)
4.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029)
4.5 South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type (2018-2029)
5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application (2018-2029)
6.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
7.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
8.3.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
10.3.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
12.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
12.3 Swine Reproductive and Respiratory Syndrome Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Swine Reproductive and Respiratory Syndrome Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Reproductive and Respiratory Syndrome Vaccine
13.3 Swine Reproductive and Respiratory Syndrome Vaccine Production Process
13.4 Swine Reproductive and Respiratory Syndrome Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Reproductive and Respiratory Syndrome Vaccine Typical Distributors
14.3 Swine Reproductive and Respiratory Syndrome Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ASCENT CORPORATION Basic Information, Manufacturing Base and Competitors
Table 4. ASCENT CORPORATION Major Business
Table 5. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 6. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ASCENT CORPORATION Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 11. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. MSD Animal Health Major Business
Table 15. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 16. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. MSD Animal Health Recent Developments/Updates
Table 18. SPAH Basic Information, Manufacturing Base and Competitors
Table 19. SPAH Major Business
Table 20. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 21. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. SPAH Recent Developments/Updates
Table 23. Ceva Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Major Business
Table 25. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 26. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ceva Recent Developments/Updates
Table 28. Chengdu TECH-BANK Biological Products Co,.Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu TECH-BANK Biological Products Co,.Ltd Major Business
Table 30. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 31. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments/Updates
Table 33. ringpu Basic Information, Manufacturing Base and Competitors
Table 34. ringpu Major Business
Table 35. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 36. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. ringpu Recent Developments/Updates
Table 38. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 39. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Major Business
Table 40. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 41. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments/Updates
Table 43. DAHUANONG Basic Information, Manufacturing Base and Competitors
Table 44. DAHUANONG Major Business
Table 45. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 46. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. DAHUANONG Recent Developments/Updates
Table 48. CAVAC Basic Information, Manufacturing Base and Competitors
Table 49. CAVAC Major Business
Table 50. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 51. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CAVAC Recent Developments/Updates
Table 53. Komipharm Basic Information, Manufacturing Base and Competitors
Table 54. Komipharm Major Business
Table 55. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 56. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Komipharm Recent Developments/Updates
Table 58. Agrovet Basic Information, Manufacturing Base and Competitors
Table 59. Agrovet Major Business
Table 60. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 61. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Agrovet Recent Developments/Updates
Table 63. Bioveta Basic Information, Manufacturing Base and Competitors
Table 64. Bioveta Major Business
Table 65. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 66. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bioveta Recent Developments/Updates
Table 68. JINYU BIO-TECNOLOGY CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 69. JINYU BIO-TECNOLOGY CO.,LTD Major Business
Table 70. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 71. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. JINYU BIO-TECNOLOGY CO.,LTD Recent Developments/Updates
Table 73. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 74. Phibro Animal Health Major Business
Table 75. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 76. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Phibro Animal Health Recent Developments/Updates
Table 78. ANHUI TIANKANG(GROUP)SHRES O., LTD Basic Information, Manufacturing Base and Competitors
Table 79. ANHUI TIANKANG(GROUP)SHRES O., LTD Major Business
Table 80. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 81. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments/Updates
Table 83. Zoetis Basic Information, Manufacturing Base and Competitors
Table 84. Zoetis Major Business
Table 85. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 86. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Zoetis Recent Developments/Updates
Table 88. WINSUN BIO Basic Information, Manufacturing Base and Competitors
Table 89. WINSUN BIO Major Business
Table 90. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 91. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. WINSUN BIO Recent Developments/Updates
Table 93. PULIKE BIOLOGICAL ENGINERING,INC. Basic Information, Manufacturing Base and Competitors
Table 94. PULIKE BIOLOGICAL ENGINERING,INC. Major Business
Table 95. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product and Services
Table 96. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments/Updates
Table 98. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 101. Market Position of Manufacturers in Swine Reproductive and Respiratory Syndrome Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Swine Reproductive and Respiratory Syndrome Vaccine Production Site of Key Manufacturer
Table 103. Swine Reproductive and Respiratory Syndrome Vaccine Market: Company Product Type Footprint
Table 104. Swine Reproductive and Respiratory Syndrome Vaccine Market: Company Product Application Footprint
Table 105. Swine Reproductive and Respiratory Syndrome Vaccine New Market Entrants and Barriers to Market Entry
Table 106. Swine Reproductive and Respiratory Syndrome Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Region (2018-2023) & (USD/Unit)
Table 112. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Region (2024-2029) & (USD/Unit)
Table 113. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Type (2018-2023) & (USD/Unit)
Table 118. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Type (2024-2029) & (USD/Unit)
Table 119. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Application (2018-2023) & (USD/Unit)
Table 124. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Application (2024-2029) & (USD/Unit)
Table 125. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Swine Reproductive and Respiratory Syndrome Vaccine Raw Material
Table 166. Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine Raw Materials
Table 167. Swine Reproductive and Respiratory Syndrome Vaccine Typical Distributors
Table 168. Swine Reproductive and Respiratory Syndrome Vaccine Typical Customers
List of Figures
Figure 1. Swine Reproductive and Respiratory Syndrome Vaccine Picture
Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Active Vaccine Examples
Figure 5. Inactivated Vaccines Examples
Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Government Tender Examples
Figure 9. Market Sales Examples
Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
Figure 73. Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
Figure 74. Swine Reproductive and Respiratory Syndrome Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Swine Reproductive and Respiratory Syndrome Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 78. Swine Reproductive and Respiratory Syndrome Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
